Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Daniel J Bratton"'
Autor:
Thomas Gaisl, Annette M Wons, Valentina Rossi, Daniel J Bratton, Christian Schlatzer, Esther I Schwarz, Giovanni Camen, Malcolm Kohler
Publikováno v:
PLoS ONE, Vol 11, Iss 4, p e0152994 (2016)
BACKGROUND:A high P-wave duration and dispersion (Pd) have been reported to be a prognostic factor for the occurrence of paroxysmal atrial fibrillation (PAF), a condition linked to obstructive sleep apnea (OSA). We tested the hypothesis of whether a
Externí odkaz:
https://doaj.org/article/1a742c02be8c4ec193104a97f930ab4c
Autor:
Alison McMillan, Daniel J Bratton, Rita Faria, Magda Laskawiec-Szkonter, Susan Griffin, Robert J Davies, Andrew J Nunn, John R Stradling, Renata L Riha, Mary J Morrell
Publikováno v:
Health Technology Assessment, Vol 19, Iss 40 (2015)
Background: The therapeutic and economic benefits of continuous positive airway pressure (CPAP) for the treatment of obstructive sleep apnoea syndrome (OSAS) have been established in middle-aged people. In older people there is a lack of evidence. Ob
Externí odkaz:
https://doaj.org/article/52a21f7388e94df6a3bfe1e34a05b098
Autor:
Imran Howell, Daniel J. Bratton, Gareth Hynes, Steven W. Yancey, Liam G. Heaney, Ian D. Pavord, Rahul Shrimanker
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/3b8c5c21aa064df2a187442b962f2729
Autor:
Adam Gater, Chloe Tolley, Rebecca Williams‐Hall, Claire Trennery, Helena Bradley, Mirko V. Sikirica, Linda Nelsen, Ana R. Sousa, Daniel J. Bratton, Robert Chan, Robyn vonMaltzahn
Publikováno v:
OTO Open, Vol 7, Iss 4, Pp n/a-n/a (2023)
Abstract Objective To date, no patient‐reported outcome measures have been specifically developed to assess pharmacological treatment effect in participants with severe chronic rhinosinusitis (CRS) with recurrent bilateral nasal polyps (NP). These
Externí odkaz:
https://doaj.org/article/a07764f2f4a24a06871016cfabfa7a30
Autor:
Frank C. Albers, Daniel J. Bratton, Necdet B. Gunsoy, Sarah M. Cockle, Rafael Alfonso‐Cristancho, Gert‐Jan Braunstahl
Publikováno v:
The Clinical Respiratory Journal. 16:252-258
Patients with severe eosinophilic asthma experience daily activity limitations and reduced productivity at work. Using anonymized individual patient-level data from two previously conducted randomized, double-blind, placebo-controlled studies (MENSA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::767b502a086754b8f0acb3adf317dec4
https://doi.org/10.1111/crj.13474
https://doi.org/10.1111/crj.13474
Autor:
Paul W. Jones, Dave Singh, Guy Brusselle, Nicolas Roche, David A. Lipson, Peter Lange, Daniel J. Bratton, Fernando J. Martinez, Mark T. Dransfield, Benjamin Hartley, Thomas C. Corbridge, Neil Barnes, Alberto Papi, C.E. Jones, MeiLan K. Han, Chris Compton, Robert A. Wise, David Halpin
Publikováno v:
Chest. 158:A1666-A1671
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d52bc2517f8209147ca996b51115b36f
https://doi.org/10.1016/j.chest.2020.08.1495
https://doi.org/10.1016/j.chest.2020.08.1495
Autor:
Daniel J. Bratton, Frank C. Albers, Ian D. Pavord, Roland Buhl, Eugene R. Bleecker, Pascal Chanez, Elisabeth H. Bel, Steven W. Yancey, Peter H. Howarth
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 6, Iss 3 (2020)
article-version (VoR) Version of Record
ERJ Open Research, Vol 6, Iss 3 (2020)
Background Mepolizumab (100 mg delivered s.c. every 4 weeks) is indicated for add-on maintenance treatment for patients with severe eosinophilic asthma. Mepolizumab has been shown to reduce exacerbations and the requirement for daily oral corticoster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f47d30f1bbb2776ee2b3a53cabb925
https://doi.org/10.1183/23120541.00068-2020
https://doi.org/10.1183/23120541.00068-2020
Autor:
Peter H. Howarth, Geoffrey Chupp, Daniel J. Bratton, Steven G. Smith, Frank C. Albers, Guy Brusselle, Linda M. Nelsen, Eric S. Bradford, Claus Bachert
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:1713-1715
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cca21ecfdef821d876261002c2bf71b9
https://doi.org/10.1016/j.jaci.2020.02.002
https://doi.org/10.1016/j.jaci.2020.02.002
Autor:
Mark C. Liu, Frank C. Albers, Charlene M. Prazma, Soichiro Hozawa, Marc Humbert, Steven W. Yancey, Daniel J. Bratton
Publikováno v:
Allergy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b827805340d62150d2ea455fa2ccbfef
http://europepmc.org/articles/PMC7216893
http://europepmc.org/articles/PMC7216893
Autor:
Peter H. Howarth, Carl B. Abbott, Elisabeth H. Bel, Alberto Papi, Oliver N. Keene, Daniel J. Bratton, Neil R.W. Martin, Robert Chan
Publikováno v:
Respiratory Medicine, 191:106065. W.B. Saunders Ltd
Martin, N, Papi, A, Bratton, D J, Chan, R, Howarth, P H, Abbott, C B, Keene, O N & Bel, E H 2022, ' Comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020] ', Respiratory Medicine, vol. 191, 106065 . https://doi.org/10.1016/j.rmed.2020.106065
Martin, N, Papi, A, Bratton, D J, Chan, R, Howarth, P H, Abbott, C B, Keene, O N & Bel, E H 2022, ' Comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020] ', Respiratory Medicine, vol. 191, 106065 . https://doi.org/10.1016/j.rmed.2020.106065
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5bca5b0a7601da40e0f4854c76b21da
https://pubmed.ncbi.nlm.nih.gov/35090688
https://pubmed.ncbi.nlm.nih.gov/35090688